Rheumatoid arthritis - tocilizumab (rapid review TA198): consultee and commentator comments on the ACD
Rheumatoid arthritis - tocilizumab (rapid review TA198): comment received from MSD
Rheumatoid arthritis - tocilizumab (rapid review TA198): comment received from Roche
Rheumatoid arthritis - tocilizumab (rapid review TA198): comment received from the British Society of Rheumatology
Rheumatoid arthritis - tocilizumab (rapid review TA198): comment received from the Royal College of Nursing
Rheumatoid arthritis - tocilizumab (rapid review TA198): comment received from Abbott
Rheumatoid arthritis - tocilizumab (rapid review TA198): comment received from Pfizer
This page was last updated: 21 December 2011